New findings indicate as many as 96% of men with positive PSA labs who show insignificant or slow-growing cancer on MRI can safely forego biopsy for three or more years. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

“With this signal about the public’s preference for notification, the question for health systems and policymakers is not whether to notify patients but when and how.” 

In patients with suspected stroke, contrast allergies present a significant dilemma, as contrast-enhanced imaging is often used to guide treatment decisions.

Kit Crancer, RBMA board member, speaks with Radiology Business about key legislative developments on the Hill that will affect the specialty.